High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

High-dose melphalan (HDM) plus stem cell transplantation is an effective treatment for light-chain amyloidosis (AL), but is associated with high treatment-related mortality in patients with cardiac involvement. We studied 187 patients with cardiac involvement with AL who underwent HDM between 1996 a...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Madan, Sumit, Kumar, Shaji K., Dispenzieri, Angela, Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Rajkumar, S. Vincent, Hogan, William J., Leung, Nelson, Grogan, Martha, Gertz, Morie A.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2012
Предметы:
Clinical Trials and Observations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3277349/
https://ncbi.nlm.nih.gov/pubmed/22147893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-07-370031
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы